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Summary The association between coffee consumption and the incidence rate of breast cancer has been
analysed in 152 incident cases ofbreast cancer that developed among 14,593 Norwegian women during a mean
follow-up of 12 years. At the time of inquiry they were between 35 and 51 years of age, and at the end of
follow-up between 46 and 63. There was an overall weak negative association between daily intake of coffee
and risk of breast cancer, which was not statistically significant. However, the association with coffee varied,
depending on the body mass index (BMI) of the women. In the lean (Quetelet<24; population mean) there
was an inverse relation between coffee intake and risk of breast cancer (X2 trend = 5.07, P = 0.02). In this
group, women who reported drinking 5 cups or more per day had an age-adjusted IRR of 0.5 (95%
confidence intervals, 0.3 and 0.9) compared to women who had 2 cups or less. In women with Quetelet's index
equal to or greater than 24 there was a positive relation between coffee intake and breast cancer risk (X2
trend = 2.33, P = 0.13), where the corresponding age-adjusted IRR was 2.1 (95% confidence intervals, 0.8 and
5.2). This interaction effect between coffee intake and BMI was statistically significant (X2 interaction = 10.2,
3 d.f., P = 0.02). In summary, the results of this study suggest that coffee consumption reduces the risk of
breast cancer in lean women, whereas coffee might have the opposite effect in relatively obese women.
The hypothesis that coffee consumption may be associated
with the risk of breast cancer has been related to the methyl-
xanthines (caffeine, theophylline, and theobromine) contained
in coffee (Rohan & Bain, 1987). Among seven case-control
studies, six have found a positive, but not statistically
significant association with coffee drinking (Lubin et al.,
1981; Lawson et al., 1981; Mansel et al., 1982; Rosenberg et
al., 1985; La Vecchia et al., 1986; Rohan & McMichael,
1988). The remaining study displayed a statistically
significant negative association (Lubin et al., 1985). Two
prospective studies have detected weak negative associations
between coffee consumption and breast cancer risk, both of
which were not statistically significant (Snowdon & Phillips,
1984; Jacobsen et al., 1986). There is no clear experimental
evidence suggesting that coffee is related to mammary car-
cinogenesis. In fact, the available information shows con-
tradicting effects of coffee (Minton et al., 1983; Rothwell,
1974).
In this prospective study of 14,593 Norwegian women we
provide epidemiological evidence that coffee consumption
may be related to the risk of breast cancer.
Methods
Between 1974 and 1977 all women 35-49 years of age who
were living in three separate counties in Norway were invited
to participate in a health screening examination organised by
the National Health Screening Service (Bjartveit et al., 1979,
1983). Its main purpose was to collect information on risk
factors that have been associated with cardiovascular disease.
Thus, the primary questionnaire, which was included with
the invitation, had no questions related to risk factors for
breast cancer, such as age of menarche, age at first full term
pregnancy, and exact age at menopause.
A total of 24,617 (93.8%) women attended the screening.
At the screening site all participants in one county were given
a food frequency questionnaire to be filled in and returned
from their home, and in the two other counties subsamples
of the population were given the questionnaire. In all, 14,764
(95%) returned questionnaires with information on coffee
consumption. The official 11-digit identification number fac-
ilitated linkage to the Norwegian Cancer Registry and
identified 152 incident cases of breast cancer that had been
diagnosed and reported during a mean follow-up of approx-
imately 12 years. Ninety-one cancers had developed in
women younger than 51, and 61 in women aged 51 or older.
The age of 51 was arbitrarily chosen as a dividing line for
allocating breast cancers to a pre- or post-menopausal group,
and it can only serve as a rough separation between the
groups. To reduce a potential bias due to preclinical changes
in dietary habits, 171 cancer cases (including breast cancer)
that had been diagnosed prior to or during the calendar year
of examination were excluded, thus resulting in 14,593 wo-
men found to be eligible for analysis.
The food frequency questionnaire has been described else-
where (Solvoll et al., 1989), but the main question related to
coffee consumption was phrased to obtain information on
the number of cups of coffee one would usually drink per
day, and the respondents could select among six fixed alter-
native categories. Information on coffee has been compared
to data from a 24-hour recall among a subsample of the
participants (Solvoll, 1983), and it was concluded that the
questionnaire produced fairly reliable information on intake
of items that were consumed on a regular, daily basis (e.g.
coffee consumption).
Body mass index (BMI) was computed as the measured
weight (in kg) divided by the squared value of the measured
height (in metres) to provide Quetelet's index. Total serum
cholesterol was measured at the central laboratory (Bjartveit
et al., 1979, 1983), according to the method used in the Lipid
Research Clinics Program, and information on cigarette
smoking was obtained from the primary questionnaire.
In the analysis, coffee consumption has been divided into
four categories. Very few women abstained from coffee, and
abstainers and low consumers (1-2 cups per day) were
therefore included in the lowest (reference) category of in-
take. For each person belonging to a certain frequency
category, observation years at risk of developing breast
cancer were computed as the number of years accumulated
from the screening examination until withdrawal in the year
of diagnosis, at death from a cause other than breast cancer,
or at the end of follow-up. Years at risk of developing
disease before 51 years were censored when a person reached
this age, and years at risk of developing breast cancer at 51
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years or later were computed from the time a person reached
age 51 and until withdrawal. This procedure allowed com-
parison of person-time based incidence rates of breast cancer
for each category of daily coffee consumption, yielding over-
all estimates, and distinguishing diagnosis made before and
after the age of 51, roughly approximating pre- and post-
menopausal breast cancer incidence.
Incidence rate ratios (IRR) were computed as the rate in a
specific category of coffee intake divided by the estimated
rate in the reference group of lowest intake. The precision of
the IRR estimates was assessed by 95% confidence intervals
(CI) using Mietinnen's test-based method applying Mantel-
-Haenszel X2 statistics (Kleinbaum et al., 1982). The effect of
age was adjusted using the direct method for five-year age
categories of person years. Adjustment for other covariables
and tests for linear trend followed the Mantel-Haenszel
methods (Rothman, 1986). Testing for interaction was per-
formed by fitting the (cumulative incidence) data to multiple
logistic models, comparing the maximum likelihood statistics
of a model which contained a product between body mass
index (two categories) and coffee consumption (four cate-
gories) to a model where this term was omitted.
Results
We first examined the relation of daily coffee consumption
with age, body height, body mass index (BMI), total serum
cholesterol, and cigarette smoking (Table I), to evaluate
whether any one of these factors might distort the association
between coffee intake and risk of breast cancer. There was no
difference in coffee consumption between age groups, and
after adjustment for age there was no relation between coffee
intake and body height. We found a weak tendency for more
obese women to drink more coffee, and there was a stronger
association between total serum cholesterol and coffee con-
sumption, as there was a tendency for women who smoked
10 or more cigarettes per day to report higher intakes of
coffee per day than nonsmoking women.
In this cohort, women who were 163 cm (population me-
dian) or taller had an increased risk of breast cancer (age-
adjusted IRR = 1.5, P = 0.02), and relative overweight was
inversely related to breast cancer risk. Thus, the age-adjusted
IRR of women whose Quetelet's index was 24 (population
median) and above was 0.7 (P = 0.03) compared to women
with Quetelet lower than 24. There was a weak, but not
statistically significant negative association between total ser-
um cholesterol and risk of breast cancer. Women whose
cholesterol was equal to or above the population median
(6.6 mmol 1') had an age-adjusted IRR of 0.8 (P = 0.20).
There was no difference in risk between women who smoked
10 or more cigarettes per day and nonsmoking women (age-
adjusted IRR = 1.1, P= 0.67).
We observed an overall weak, but not statistically
significant inverse relation between coffee consumption and
risk of breast cancer, which was confined to an effect in
women who were diagnosed with disease before the age of 51
(Table II). To explore whether this might be an effect of truly
premenopausal cancer, only cases diagnosed at age 47 or
younger were examined (data not shown), but this did not
materially alter the negative association.
Body mass index was inversely related to breast cancer
risk, and simultaneously positively associated with coffee
consumption. We therefore examined the relation between
daily coffee intake and breast cancer risk for lean (Que-
telet<24) and more obese (Quetelet > 24) women separately
(Table III). The effect of coffee differed strongly between the
two strata of BMI (X2 interaction = 10.23, 3 d.f., P = 0.02),
suggesting that body size might exert an interaction effect on
the association between coffee drinking and breast cancer.
Among the leaner women, those who drank 5 or more cups
per day had an age-adjusted IRR of 0.5 (95% Cl, 0.3 and
0.9), compared to women who had 2 cups or less. The
negative relation with coffee consumption yielded a statis-
tically significant test for linear trend (X2 trend = 5.07,
P = 0.02). In the more obese stratum the corresponding age-
adjusted IRR was 2.1 (95% Cl, 0.8 and 5.2), but the trend
test was not statistically significant for this association (x2
trend = 2.90, P = 0.09). Further adjustments for cigarette
smoking and total serum cholesterol did not materially
change these results.
Discussion
In this prospective study, we detected an association between
coffee consumption and breast cancer which was dependent
on the body size of the women. In lean women (Que-
telet<24) there was a 50% decreased risk of breast cancer
associated with drinking five or more cups of coffee per day
compared to drinking two cups or less. In more obese
women (Quetelet > 24) the corresponding relation displayed
a two-fold increase in breast cancer risk. The test for interac-
tion between coffee intake and body mass was statistically
significant (P= 0.02) on a multiplicative scale, and the in-
verse relation between coffee consumption and breast cancer
in lean women was precisely estimated and yielded a statis-
tically significant test for linear trend.
Previous studies have displayed contradicting relations be-
tween coffee consumption and breast cancer. However, one
large case-control study (Lubin et al., 1985) found a nega-
tive association, and two prospective studies (Snowdon &
Philips, 1984; Jacobsen et al., 1986) also reported inverse
effects of coffee, but these were not statistically significant.
No study that we are aware of has made a distinction
between coffee effects among lean and more obese women.
Table I Percentagesofwomenaccording tocategories ofdailycoffeeconsumption, within the factorsage,
body height, body mass index (Quetelet), total serum cholesterol, and current cigarette smoking
Daily coffee consumption
2 cups 3-4 cups 5-6 cups 7 cups
Age (at entry)
35-39 (n = 4,559) 17 37 30 16
40-44 (n = 4,506) 15 39 31 15
45-51 (n= 5,528) 15 42 29 13
Body height
<163cm 15 41 29 15
> 163 cm 16 39 30 15
Body mass index
<24 kg m-2 17 40 29 14
> 24 kg m-2 14 40 31 16
Total serum cholesterol
<6.6 mmol I` 19 41 28 13
6.6mmoll ' 12 39 32 17
Cigarette smoking
Non-smoker 21 46 25 8
> 10 cig per day 9 27 36 29COFFEE CONSUMPTION AND BREAST CANCER 269
Table II Age-adjusted incidence rate ratio (IRR) ofbreast cancer, according to daily consumption ofcoffee, for (A) all cases, (B) cases diagnosed
before age 51, and (c) cases diagnosed at age 51 or latera
Daily coffee consumption
2 cups 3-4 cups S-6 cups 7 cups X2
A. All cases
Cases 27 62 42 21
Person years 24611 63659 48168 23759
Age-adjusted IRR 1.0 0.9 0.8 0.8 0.81
95% confidence limits (0.6, 1.4) (0.5, 1.3) (0.5, 1.4) P=0.37
B. Cases<51
Cases 18 36 23 14
Person years 17089 42375 32741 16665
Age-adjusted IRR 1.0 0.8 0.7 0.8 0.83
95% confidence limits (0.5, 1.4) (0.4, 1.2) (0.4, 1.6) P=0.36
C. Cases > 51
Cases 9 26 19 7
Person years 7773 21964 15901 7380
Age-adjusted IRR 1.0 1.0 1.0 0.8 0.08
95% confidence limits (0.5, 2.2) (0.5. 2.3) (0.3, 2.3) P=0.77
aData are based on 152 cases ofbreast cancer that developed during a mean follow-up of 14,593 Norwegian women, who were between 35 and 51
years at examination.
Table III Age-adjusted incidence rate ratio (IRR) ofbreast cancer, according to daily coffee consumption in lean women (Quetelet's index<24),
and in more obese (Quetelet's index > 24) women
Daily coffee consumption
<2 cups 3-4 cups 5-6 cups >7cups X2
Quetelet <24
Cases 22 40 17 11
Person years 13743 32355 24025 11367
Age-adjusted IRR 1.0 0.8 0.4 0.6 5.07
95% confidence limits (0.5, 1.3) (0.2, 0.8) (0.3, 1.2) P= 0.02
Quetelet > 24
Cases 5 22 25 10
Person years 10868 31304 24143 12392
Age-adjusted IRR 1.0 1.5 2.3 1.8 2.33
95% confidence limits (0.6, 4.0) (0.9, 5.8) (0.6, 5.4) P = 0.13
X2 interactiona = 10.23, 3 d.f., P = 0.02
aInteraction between coffee consumption (4 categories) and BMI (2 categories).
Approximately 95% of the participating women returned
the dietary questionnaire. Although the remaining 5% may
represent a selected part of the population with respect to
coffee consumption, it seems unlikely that these would ma-
terially affect the associations detected with breast cancer.
Coffee intake was reliably measured (Solvoll, 1983, 1989) and
showed that consumption was generally high, with a popula-
tion mean of 3.5 cups per day, and that very few women
abstained from coffee. Despite a low number of abstainers,
there was sufficient variation in consumption to construct 4
separate categories of intake. The 24-hour recall indicated
that the accuracy of reporting was fairly high. Although
some misclassification could not have been avoided, this
would probably be non-differential and not associated with
future risk of developing breast cancer. If anything, this
suggests that misclassification would produce results that are
an underestimate of the real effects of coffee.
A limitation of this study is the lack of information on
factors that are known to affect the risk of breast cancer.
Apart from being independent risk factors for the disease in
the absence ofthe exposure under study, potentially confoun-
ding variables should be associated with the exposure (Roth-
man, 1986). Consequently, intake of coffee should be assoc-
iated with variables like age at menarche and age at first full
term pregnancy for confounding from these factors to be
anticipated in the data. We attempted to make an adjustment
for reproductive history by controlling for the effect of
occupational status (housewife/not housewife), but this did
not materially alter the observed relation with coffee con-
sumption.
There are indications that among premenopausal women
those who are lean are at increased risk of developing breast
cancer compared to women who are more obese (Willett et
al., 1985). In this study the oldest participant was still only
63 years at the end of follow-up. This indicates that a
majority of the cases were premenopausal at the onset of
disease, and most certainly were premenopausal at initiation
and during the preclinical induction phase of disease. Since
the protective effect of obesity on the risk of breast cancer
appears to be restricted to premenopausal women, this may
indicate that there exists a crucial relationship between body
mass and ovarian activity. Then the results of this study
might suggest that some component contained in coffee (pos-
sibly methylxanthines) could have a role to play in this
relationship. Whereas large daily doses of coffee may favour-
ably affect the risk of developing breast cancer in lean
women, more obese women might achieve a benefit from
restricting their daily coffee intake.
This research is based on data made available by the National
Health Screening Service and the Cancer Registry of Norway in
cooperation with the Division of Dietary Research, the University of
Oslo. Dr Vatten is a research fellow of the Norwegian Cancer
Society.
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